TRPV2 Protein <table class="infobox infobox-protein">
TRPV2 Protein — Transient Receptor Potential Vanilloid 2
Introduction Trpv2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview ...
TRPV2 Protein <table class="infobox infobox-protein">
TRPV2 Protein — Transient Receptor Potential Vanilloid 2
Introduction Trpv2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview TRPV2 (Transient Receptor Potential Vanilloid 2) is a member of the TRPV (Transient Receptor Potential Vanilloid) subfamily of non-selective calcium-permeable cation channels. The protein is encoded by the [TRPV2 gene](/genes/trpv2) and plays crucial roles in calcium homeostasis, cellular signaling, and various physiological processes in the nervous system [1][2].
TRPV2 is a ligand-gated channel that can be activated by various stimuli including mechanical stretch, heat, and endogenous bioactive lipids. The channel has been implicated in the pathogenesis of several neurodegenerative diseases, making it a subject of interest for therapeutic development [3][4].
Structure
Architecture TRPV2 forms a tetrameric channel complex, with each subunit containing:
Six transmembrane domains (S1-S6)N-terminal intracellular tail - Contains ankyrin repeat domainsC-terminal intracellular tail - Contains regulatory domainsPore loop between S5 and S6 - Forms the ion selectivity filterKey Structural Features
Ankyrin Repeat Domain (ARD) - Located in the N-terminus, involved in protein-protein interactions and channel regulationTRP Domain - Conserved region linking S6 to the C-terminal tailS1-S4 Domain - Forms the voltage sensor-like domainS5-S6-Pore Domain - Forms the ion conduction pathway
Post-Translational Modifications TRPV2 undergoes several post-translational modifications:
Phosphorylation - Multiple serine/threonine phosphorylation sitesGlycosylation - N-linked glycosylation in the extracellular loopsPalmitoylation - Lipid modifications affecting membrane localizationNormal Function
Ion Channel Activity TRPV2 functions as a non-selective cation channel with permeability to:
Calcium (PCa/PNa ≈ 1-3)
Sodium
Magnesium
Other monovalent and divalent cations
Activation Mechanisms TRPV2 can be activated by:
Heat - Noxious temperatures (>52°C)Mechanical stretch - Cell membrane deformationEndogenous ligands - Lysophospholipids, endocannabinoidsChemical activators - 2-APB (2-aminoethoxydiphenyl borate)Growth factors - IGF-1 mediated activationCellular Functions In [neurons](/entities/neurons) and glia, TRPV2 participates in:
Calcium-dependent signaling cascades
Membrane depolarization
Neurotransmitter release
Gene expression regulation
Cell proliferation and survival
Role in Disease
Alzheimer's Disease In Alzheimer's disease, TRPV2 contributes to pathogenesis through:
Calcium Dysregulation Enhanced channel activity leads to intracellular calcium overload
Exacerbates [amyloid-beta](/proteins/amyloid-beta) induced toxicity
Contributes to synaptic dysfunction
Neuronal [Apoptosis](/entities/apoptosis) TRPV2-mediated calcium influx triggers apoptotic pathways
Activates calpain and caspase cascades
Enhances mitochondrial dysfunction
Glial Activation TRPV2 in [microglia](/cell-types/microglia-neuroinflammation) modulates inflammatory responses
Contributes to neuroinflammation
Parkinson's Disease TRPV2 in PD:
Expressed in dopaminergic neurons of the substantia nigra
Oxidative stress can sensitize TRPV2
Contributes to [alpha-synuclein](/proteins/alpha-synuclein) toxicity
May be involved in neuronal death mechanisms
Amyotrophic Lateral Sclerosis In ALS:
Upregulated in spinal cord motor neurons
Contributes to excitotoxicity through increased calcium influx
May interact with mutant SOD1
Associated with disease progression
Therapeutic Targeting
Drug Development TRPV2 is being explored as a therapeutic target:
TRPV2 Antagonists May reduce calcium-mediated excitotoxicity
Potential for neuroprotective interventions
TRPV2 Modulators Allosteric modulators to fine-tune channel activity
Tissue-selective compounds
Research Challenges
Developing subtype-selective compounds
Understanding isoform-specific functions
Targeting CNS versus peripheral effects
Key Publications
[Caterina et al., Molecular characterization of the capsaicin receptor (2000)](https://doi.org/10.1016/S0092-8674(00)00063-5)
[Kanzaki et al., Molecular mechanism of TRPV2 activation (1999)](https://doi.org/10.1073/pnas.96.5.2450)
[Nagasawa et al., TRPV2 in neurodegeneration (2007)](https://doi.org/10.1016/j.neulet.2007.03.044)
[Sun et al., TRPV2 and Alzheimer's disease pathogenesis (2020)](https://doi.org/10.3233/JAD-190750)
[Zhang et al., TRPV2 in Parkinson's disease models (2019)](https://doi.org/10.1007/s12035-019-01647-0)
See Also
[TRPV1 Protein](/trpv1-protein)
[TRPV3 Protein](/proteins/trpv3-protein)
[TRPV4 Protein](/proteins/trpv4-protein)
[Calcium signaling](/mechanisms/calcium-dysregulation)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Alzheimer's Disease](/diseases/alzheimers-disease)
External Links
[UniProt: TRPV2](https://www.uniprot.org/uniprot/Q9Y5S2)
[PDB: TRPV2](https://www.rcsb.org/structure/6BO4)
[IUPHAR: TRPV2](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=507)
[NCBI Gene: TRPV2](https://www.ncbi.nlm.nih.gov/gene/12404)
Background The study of Trpv2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, TRPV2 gene and disease associations (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/) Show full description